DAWN - Balance Sheet - Day One Biopharmaceuticals, Inc.

Current Liabilities	73.5 M
Accounts Payable	3.26 M
Short-Term Debt	0
Other Current Liabilities	70.2 M
Non-Current Liabilities	6.59 M
Long-Term Debt	0
Other Non-Current Liabilities	6.59 M

Millions

	Dec-2024	Dec-2023	Dec-2022	Dec-2021	Dec-2020	Dec-2019
ASSETS
Cash & Cash Equivalents	125.0	230.8	85.3	284.3	43.7	27.3
Short Term Investments	406.8	135.6	257.0	0	0	0
Receivables	13.9	0	0	0	0	0
Inventory	3.3	0	0	0	0	0
Other Current Assets	13.4	8.9	5.6	5.1	1.3	7 K
Total Current Assets	562.3	375.3	347.9	289.4	45.1	27.3
PP&E	4.7	0.6	0.7	0.3	0.5	0
Intangible Assets	15.6	0	0	0	0	0
Goodwill	0	0	0	0	0	0
Long Term Investments	0	0	0	0	0	0
Other Long Term Assets	0.1	0.2	0.5	0.2	0.1	0
Other Assets	0	0	0	0	0	0
Total Assets	582.8	376.0	349.1	289.8	45.7	27.3
LIABILITIES
Accounts Payable	3.3	2.6	0.3	1.7	0.2	69 K
Short Term Debt	0	0.4	0.8	0.4	0.2	0
Other Current Liabilities	68.6	26.5	15.5	6.5	1.6	2.0
Total Current Liabilities	73.5	29.5	16.6	8.7	2.0	2.0
Long Term Debt	0	0	0.4	16 K	0.2	0
Deferred Tax Income	0	0	0	0	0	0
Other Liabilities	6.6	0	0	0	92.0	30.5
Total Liabilities	80.0	29.5	17.0	8.7	94.2	32.5
EQUITY
Common Stock	10 K	9 K	7 K	6 K	2.0	2.0
Retained Earnings	(554.1)	(458.6)	(269.7)	(127.5)	(56.8)	(12.8)
Other Accumulative Comprehensive Income/Loss	84 K	9 K	71 K	0	637	111
Total Equity	502.8	346.5	(269.7)	162.3	(48.5)	(5.2)
Total Liabilities and Equity	582.8	376.0	(252.6)	(118.8)	45.7	27.3
SHARES OUTSTANDING
Common Shares Outstanding	93.6	79.8	65.5	62.0	61.9	61.9

Free